DURHAM, N.C. — Constella Group has hired two executives for the management team of its pharmaceutical product development business unit.

Richard Shea takes over as vice president of operations, and John Reynolds in the vice president for sales and marketing.

“Rich’s leadership will help strengthen and enhance our ability to provide high quality, dependable drug development services, and John’s creative and enthusiastic approach to business development will be critical to continue to build Constella’s presence in the [contract research organization] marketplace,” said Steve Smith, president of the business unit.

One of Shea’s responsibilities will be to integrate recently acquired Lineberry Research Associates into the Constella organization. Constella completed the acquisition of Lineberry, which is based in RTP, on Nov. 30.

Shea is a former chief financial officer at PharmaLinkFHI in RTP.
Reynolds has an extensive background in sales, marketing and business development in the CRO industry. He worked most recently at a Swiss-based CRO as vice president of sales and marketing.

Constella Group: www.constellagroup.com